Medicare Part D rule change would be another win for pharma’s lobbyists, analyst says
admin 20th November 2017 Uncategorised 0Pharma stands to prevail again in Washington, D.C., if a new Part D rule proposal from the Centers for Medicare & Medicaid Services comes to fruition. Last week, the agency put out potential changes to solicit feedback, with a drug pricing tweak one area under consideration.
More: Medicare Part D rule change would be another win for pharma’s lobbyists, analyst says
Source: fierce